The small GTPase Arf6 regulates endocytosis, actin dynamics, and cell adhesion, and one of its major activators is the exchange factor Arf nucleotide-binding site opener (ARNO), also called cytohesin-2 [1, 2]. ARNO must be recruited from the cytosol to the plasma membrane in order to activate Arf6, and in addition to a Sec7 nucleotide-exchange domain it contains a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides [3, 4] . ARNO and its three relatives, cytohesin-1, Grp1/cytohesin-3, and cytohesin-4, are expressed as two splice variants, with either two or three glycines in a loop in the phosphoinositide-binding pocket of the PH domain [5, 6] . The diglycine form binds PtdIns(3,4,5)P 3 with high affinity and mediates recruitment of cytohesins to the plasma membrane in response to insulin and growth factors [7, 8] . However, the triglycine form has only micromolar affinity for both PtdIns(3,4,5)P 3 and PtdIns(4,5)P 2 , affinities that are insufficient to confer membrane recruitment, raising the question of how the triglycine forms of cytohesins are regulated [5, 9] . Here we show that three related Arf-like GTPases of unknown function, Arl4a, Arl4c, and Arl4d, are able to recruit ARNO and other cytohesins to the plasma membrane by binding to their PH domains irrespective of whether they are in the diglycine or triglycine form. The Arl4 family thus defines a signal-transduction pathway that can mediate the plasma-membrane recruitment of cytohesins independently of a requirement for the generation of PtdIns(3,4,5)P 3 .
Results and Discussion
The Arf family of small GTP-binding proteins includes Arf1 and Sar1, which direct the formation of coated transport vesicles at the Golgi and endoplasmic reticulum (ER), respectively, and Arf6, which acts at the plasma membrane to regulate cytoskeletal organization and endocytic processes [2, 10] . In addition, mammals have over 20 structurally related Arf-like (Arl) GTPases, of which Arl1 acts at the Golgi to recruit coiled-coil proteins and other vesicle-traffic machinery, and Arls 2, 3, and 6 control the formation of microtubular structures [11] [12] [13] . The function of the other Arls is less well understood, and thus we have been examining their intracellular distribution. Human Arl4a, Arl4c, and Arl4d are three closely related Arls that appear to have diverged in recent evolution because they all have orthologs in other vertebrates but a single ortholog in Drosophila [14] [15] [16] . They are distinguished from other members of the Arf family by a C-terminal extension of 10-15 mostly basic residues, as well as a short insertion in the loop between the two switch regions ( Figure 1A , and [11] ).
When tagged versions of all three Arl4 isoforms were expressed in HeLa cells, they localized to the plasma membrane, with Arl4d also showing some nuclear accumulation ( Figure 1B ). Most other Arf family members associate with membranes via an N-terminal amphipathic helix, which starts with an N-terminal myristoyl group and is only fully exposed in the GTP-bound form [11] . The human Arl4 family members all have at position 2 a well-conserved glycine that is part of the recognition motif for N-myristoyltransferase, and Arl4a has been shown to be a substrate for this enzyme [17] . Figure 1C shows that plasma-membrane binding of Arl4c was lost upon the mutation of Gly 2 to Ala or the mutation of Thr 34 to Asn, a change known in other Arfs to allow only GDP binding [18] . Arl4cT27N accumulates to the same level as the wild-type in transfected cells, but the mutation causes bacterially expressed GST-Arl4c to be predominantly GDP bound (20% GTP versus 60% for the wild-type, data not shown). However, removal of the C-terminal basic extension also resulted in the displacement of Arl4a from the plasma membrane ( Figure 1C ). Basic stretches can bind electrostatically to the acidic phospholipids that are uniquely enriched in the cytoplasmic leaflet of this membrane, and indeed it has recently been found that acute depletion of plasmamembrane PtdIns(4,5)P 2 causes the displacement of 39 different plasma-membrane GTPases that contain basic stretches, including Arl4c [19] . The C-terminal basic extensions of the Arl4 family may thus ensure a plasma-membrane location by stabilizing the interactions formed by the N-terminal amphipathic helices, which are shorter or less hydrophobic than those of other Arf family members.
To identify effectors that the Arl4 family recruits to the plasma membrane, we performed a yeast two-hybrid screen of a human cDNA library with forms of Arl4a and Arl4d carrying a mutation that in other Arfs prevents GTP hydrolysis and hence locks them in a GTP-bound form. Candidate interactors were rescreened by determining whether coexpression of Arl4a or Arl4d affected the localization of an epitope-tagged, full-length form of the protein. The only protein to show such an effect was the Arf6 guanine-nucleotide exchange factor (GEF) ARNO, which appeared multiple times in the screens with both Arl4a and Arl4d. Figure 2A shows that when expressed by itself ARNO is cytosolic, but coexpression of Arl4a, Arl4c, or Arl4d causes it to accumulate at the plasma membrane. Similar results were obtained with both the diglycine and triglycine forms and with both an N-terminal RFP in live cells ( Figure 2A ) and a C-terminal myc tag in fixed cells (data not shown). This relocation apparently requires the GTP-bound state because it was not observed with Arl4a containing the T34N mutation that favors GDP binding (Figure 2A ). ARNO is one of four closely related cytohesins that all contain a Sec7 domain that has GEF activity and a C-terminal pleckstrin homology (PH) domain (Figure 2A ). Expression of truncated forms of ARNO (triglycine) containing one or the other of these domains demonstrated that the C-terminal region containing the PH domain is necessary and sufficient for relocation to the plasma membrane in response to Arl4a-d ( Figures 2B and 2C) .
To determine whether ARNO can bind directly to these GTPases, we expressed a GST fusion to Arl4d in E. coli as either a T35N form or a Q80L form that lacks the catalytic residue for GTP hydrolysis and hence will accumulate with GTP bound. These GST fusions were immobilized on agarose and incubated with lysates from COS cells transfected with plasmids expressing ARNO or the truncated forms. Figure 3 shows that both full-length ARNO and the C-terminal PH-domaincontaining fragment showed a strong preference for binding to the GTP form of Arl4d and did not interact significantly with an irrelevant GTPase, Arl1. Likewise, PH domains from two other proteins (OSBP and spectrin) showed no binding to Arl4d ( Figure 3B ). We found a small but reproducible amount of GTP-dependent binding of the N-terminal part of ARNO to Arl4d, suggesting that there may be a second interaction with this part of the protein, but if this does occur in vivo, it is neither necessary nor sufficient for plasma-membrane recruitment. ARNO, like the other cytohesins, is expressed in two alternatively spliced forms that have two or three glycines in a loop in the phosphoinositide-binding site of the PH domain and differ in phosphoinositide-binding properties [5, 6, 20] . Both forms of ARNO are recruited to the plasma membrane by the Arl4 family (Figure 2 ), and the presence of the diglycine or triglycine splice variant in ARNO did not affect its ability to bind Arl4d ( Figure 3A ). To confirm that the binding between Arl4d and ARNO was direct, we expressed a His-tagged form of the C terminus of ARNO in E. coli, and this recombinant protein was also found to bind efficiently to the GTP-bound form of Arl4d ( Figure 3C ). It has recently been reported that on one face of cytohesin PH domains there are two conserved residues that are directed toward the solvent but are not required for phosphoinositide binding [21] . These residues, Ile 303 and Lys 336, are invariant in all four human cytohesins and in those from other species, including Drosophila. Mutation of Ile 303 or Lys 336 respectively prevented or greatly reduced Arl4-dependent recruitment in vivo and GTP-dependent binding in vitro ( Figures 3D and 4A) , suggesting that the residues form part of the GTPase:PH domain interface. given to a pseudogene and therefore is not used for the nomenclature of this family [12] . Residues conserved in at least half of the proteins are shaded, with basic residues in red. Also shown are Arf1 and Arl1 from human and S. cerevisiae (Sc). The C-terminal regions of these proteins form an a-helix (green cylinder) that is predicted to end close to the bilayer [35] , suggesting that the basic extension of Arl4s would be able to directly contact the headgroups of acidic phospholipids. (B) Confocal micrographs of live HeLa cells expressing GFP fused to the C terminus of the indicated Arls. A similar plasmamembrane location of these proteins was observed with HA-tagged forms and with COS and NRK cells (data not shown). The initial characterization of these Arls had suggested that the C-terminal basic stretch might act as a nuclear localization signal, but the plasmamembrane location we observe is also consistent with the location reported in a recent study on Arl4c [15, 36] . (C) Confocal micrographs of live HeLa cells expressing Arl4c-GFP with the indicated mutations. The DCT construct lacks the last nine residues; a similar result was obtained for an analogous mutant of Arl4a that lacked the last eight residues (data not shown).
When examining the effect of expressing Arl4s on the distribution of ARNO, we noticed that not only was ARNO or its PH domain relocated to the plasma membrane, but also that the GTPases themselves showed increased surface staining with a diminution of the nucleocytoplasmic pool (e.g., Arl4c and Arl4d, Figure 1 versus Figure 2 ). This suggested that the PH domain was making a second interaction at the cell surface, an interaction that stabilized the plasma-membrane association of the Arl4/ARNO complex compared to that of the Arl4 alone. The PH domains of cytohesins are known to bind phosphoinositides with affinities determined by the glycine splice variant. The triglycine form of the PH domain of ARNO can bind to both PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 with similar low millimolar affinities (approximately 1-3 mM [6, 22] ). Such an affinity is not sufficient for plasma-membrane recruitment of the PH domain in vivo, even after the generation of PtdIns(3,4,5)P 3 levels high enough for recruitment of the diglycine form of ARNO [21] . However, such a low-affinity interaction could potentially contribute to plasma-membrane binding in conjunction with direct binding by the Arl4s. To determine whether the interaction with phosphoinositides makes a contribution to Arl4-dependent targeting, we mutated residues in the triglycine version of the ARNO PH domain that have previously been shown to be required for interaction with phosphoinositides [6] . These mutations did not affect the ability of the C terminus of ARNO to interact with Arl4d in vitro ( Figure 3E ). However, they abrogated the in vivo recruitment of ARNO to the plasma membrane by Arl4a, Arlc, or Arl4d ( Figure 4B , and data not shown). This indicates that recruitment of the triglycine form of ARNO to the plasma membrane by the Arl4 family is dependent on additional binding energy from an interaction with PtdIns(4,5)P 2 . However, the diglycine form of ARNO and of the closely related Grp1/cytohesin 3 not only binds to PtdIns(3,4,5)P 3 with high affinity but can also bind to PtdIns(4,5)P 2 at an affinity comparable to that of the triglycine form [5, 6] . This form of ARNO is also recruited to the plasma membrane by coexpression with Arl4 forms. This does not appear to reflect the generation of 3-phosphorylated lipids because recruitment was not blocked by the PI3-kinase inhibitor wortmannin, and indeed Arl4 coexpression did not enhance the plasma-membrane recruitment of the unrelated PH domain from the protein CRAC, which binds PtdIns(3,4)P 2 and PtdIns(3,4,5)P 3 with high affinity (data not shown) [23] . Thus it appears that both forms of ARNO can be recruited independently of PtdIns(3,4,5)P 3 by combinatorial recognition of Arl4 and PtdIns(4,5)P 2 . In some cells with PH domain and GTPase, blebbing of the plasma membrane was observed. The PH domain is known to bind PtdIns(4,5)P 2 , and the increased avidity provided by the Arl will allow it to compete more effectively with endogenous proteins for this lipid, which is known to mediate attachment to cortical actin and hence prevent blebbing.
The recruitment to the plasma membrane of several other peripheral proteins shows a similar dependence on multiple interactions, including an interaction with PtdIns(4,5)P 2 [24] . Likewise, the PH domain of several Golgi-localized proteins appears to require both the GTPase Arf1 and the phosphoinositide PtdIns(4)P [25, 26] . Although PtdIns(3,4,5)P 3 is only generated in response to external signals, PtdIns(4,5)P 2 is constitutively present at the plasma membrane, and thus this dual interaction may ensure that the recruitment of ARNO by the Arl4 family is tightly restricted to this location.
The recruitment of diglycine ARNO to the plasma membrane by PtdIns(3,4,5)P 3 has been shown to cause the accumulation of Arf6 on the same membrane [27] . We found that Arf6 could be recruited to the plasma membrane when ARNO was coexpressed with Arl4c, confirming that the ARNO recruited by an Arl4 and PtdIns(4,5)P 2 was active rather than inhibited by the interaction with Arl4 ( Figure 4C ). When ARNO carried the E156D mutation in the Sec7 domain, a mutation that is known to block exchange activity [28] , or when Arf6's T27N form, which cannot bind GTP [29, 30] , was used, such recruitment of Arf6 was not observed ( Figure 4C ). This indicates that ARNO recruited to the plasma membrane by Arl4 is able to relocate Arf6 via GTP exchange.
Our results provide an explanation for how the triglycine form of ARNO can translocate to the plasma membrane despite lacking the ability to bind phosphoinositides with high affinity. In fetal and adult human brain 90% of ARNO transcripts encode the triglycine form [20] , indicating that this form makes a major contribution to ARNO activity. Moreover, the Arl4 isoforms can also recruit the diglycine form, indicating that the diglycine form can also be activated independently of PtdIns(3,4,5)P 3 synthesis. Thus it appears that both forms of ARNO can be recruited by the Arl4 family and that the diglycine alternative splice allows the generation of a form that can also respond to PtdIns(3,4,5)P 3 signaling. ARNO has three closely related homologs in mammals: cytohesin-1, Grp1/cytohesin-3, and cytohesin-4 [20, 31] . All of these can be alternatively spliced to generate PH domains in both diglycine and triglycine forms, and at least in the case of cytohesin-1 and Grp1, only the diglycine forms have the capacity to bind PtdIns(3,4,5)P 3 with high affinity and selectivity, whereas both forms bind to PtdIns(4,5)P 2 with lower affinity [6] . Interestingly, expressed sequence tags (EST) from the tunicate Ciona intestinalis indicate that it has only one cytohesin ortholog, which exists in both diglycine and triglycine forms, implying that this alternative splice was present at the start of vertebrate evolution and before the four cytohesin genes arose by quadruplication. To extend our observations to the other three members of the cytohesin family, we examined the effect of the Arl4 family on their localization. Expression of Arl4a, Arl4c, and Arl4d was sufficient to recruit the C-terminal PH domains of cytohesin-1, Grp1/cytohesin-3, and cytohesin-4 to the plasma membrane, indicating that the Arl4 family can control the localization of all four cytohesins ( Figure S1 in the Supplemental Data available online and data not shown). It should be noted that ARNO and Grp1 or their PH-domain-containing C termini have been used as in vivo reporters of PtdIns(3,4,5)P 3 levels [32, 33] . In most cases, the presence of PtdIns(3,4,5)P 3 has been confirmed by 3-kinase (A) Anti-myc protein blots of cell lysates from COS cells transfected with plasmids expressing the indicated forms of ARNO tagged at the C terminus with myc (as in Figure 2 ). These lysates were applied to glutathione-Sepharose beads that were coated with GST fusions to the indicated forms of Arl4d (T35N, GDP-locked form; Q80L, GTP-locked form) or Arl1. After washing, the bound material was eluted with SDS and analyzed by antibody probing or protein staining to demonstrate the presence of similar amounts of the two GST-Arl4d fusions (Coomassie). The lysates represent 10% of the material applied to the beads. (B) As in (A), except that the lysates (lys) were from COS cells expressing GFP fusions to the PH domains from the Golgi sterol transporter OSBP and from spectrin [37] . (C) As in (A), except that the lysate was obtained from E. coli expressing the 149 residues of ARNO (triglycine) with an N-terminal His 6 tag, and the blot was probed with an His 6 antibody. The lane marked ''lysate'' corresponds to 2.5% of the material applied to the beads. (D and E) As in (A), except that the COS cells were transfected with a plasmid expressing the C terminus of ARNO (triglycine) with a C-terminal myc tag, or with similar plasmids with the indicated mutants in conserved residues on the flank of the PH domain (D) or in the phosphoinositidebinding site (E). The lysate represents 10% of the material applied to the beads.
inhibitors, but clearly the potential exists for this reporter to also be responsive to the Arl4 family. Because these studies are all done with exogenous proteins, further work will be required to determine what fraction of endogenous ARNO can be recruited by endogenous Arl4s and whether the latter ever makes a contribution to the recruitment of the diglycine form by PtdIns(3,4,5)P 3 or whether the GTPase and PtdIns(3,4,5)P 3 could recruit ARNO to different parts of the cell surface. The ability of the Arl4 family to recruit the cytohesins to the plasma membrane raises the question of what activates these Arl4 GTPases whose mRNAs can be detected in a wide range of tissues [15, 34] . At present, no exchange factor is known for any Arf-like GTPase, and indeed it has been reported that a small percentage of preparations of recombinant Arl4s show a high rate of spontaneous nucleotide exchange in vitro [15] . Nonetheless, our results indicate that there could be a signaling pathway that goes via the Arl4 family and can regulate the cytohesins and Arf6, and it would clearly be of interest to identify components that could activate such a pathway. ) and GFP-tagged Arf6 (or the T27N mutant) with HA-tagged Arl4c. Arf6 is recruited to the plasma membrane in the presence of Arl4c if ARNO can act as a GEF (quantification confirmed an increased surface-to-cytoplasm ratio of Arf6-GFP for wildtype ARNO versus the E156D mutant [3.7 6 1.4 versus 1.3 6 0.25; mean 6 one standard deviation from n = 10 cells, where no recruitment would be 1.0]). The GDP-locked form of Arf6 accumulates on internal structures in high-expressing cells has been reported previously [29, 30] and is not relocated to the plasma membrane by the ARNO and Arl4c combination. The cells were serum starved for 4 hr prior to fixation to avoid production of PtdIns(3,4,5)P 3 . Similar results were obtained with the triglycine ARNO, except that this experiment showed some accumulation of Arf6 at the plasma membrane in the absence of Arl4a-GFP. This was not seen with a K268R mutation in the PH domain and presumably reflects the fact that the triglycine forms of cytohesins have a higher affinity for PtdIns(4,5)P 2 than the diglycine forms [6, 22] and hence can transiently associate more readily with the plasma membrane when expressed at high levels. In such cells Arl4a-HA did not prevent Arf6-GFP association with the plasma membrane, confirming that it at least does not inhibit the action of triglycine ARNO.
